US 11319539
Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof
granted A61KA61K31/713A61K47/14
Quick answer
US patent 11319539 (Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/713, A61K47/14, A61K9/0019, A61P